Clinical Effects of Different Rocuronium Doses Used in Pediatric Rigid Bronchoscopy
Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society
Pediyatrik Rijit Bronkoskopide Uygulanan Farklı Rokuronyum Dozlarının Klinik Etkileri
INTRODUCTION: The bronchoscopy employed for the diagnostic and therapeutic purposes in the children admitting as a result of foreign body aspiration is performed with general anesthesia. In our study, we aimed to compare clinical efficacy and perioperative adverse adverse effects (broncoscophy, body movement, laryngospasm, bronchospasm, hypoxemia) by using rocuronium in varying doses in our pediatric patients who underwent rigid bronchoscopy. METHODS: Pediatric patients who were subjected to
... ere subjected to rigid bronchoscopy were included in a retrospective study. The patients receiving 0.3 mg/kg (ED95) of rocuronium were included in Group I, 0.45 mg/kg (1.5 x ED95) in Group II and 0.6 mg/kg (2 x ED95) in Group III. The patients were evaluated in terms of duration of anesthesia, duration of bronchoscopy, body movement, additional drugs and development of complications. RESULTS: Total 60 patients, 19 female and 41 male, with age in the range of 6 months-6 years were included in the study. The duration of anesthesia was longer in Group III than the other two groups. When the groups were compared with regard to body movement, bronchospasm, laryngospasm and hypoxemia during the bronchoscopy, the adverse events in Group I were found to be significantly different. Anesthesia duration and adverse effects were significantly less in Group II. DISCUSSION AND CONCLUSION: In our study is used to different rocuronium doses for pediatric rigid bronchoscopy. We consider that the dose of 0.45 mg/kg rocuronium resulted in rapid relaxation and safe ventilation in the pediatric rigid bronchoscopy patients.